Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells

Journal of Virology

Volumn 77, Issue 1, 2003, Pages 790-798

  Gosselin, Anne Sophie ^a   Simonin, Yannick ^a   Guivel Benhassine, Florence ^a   Rincheval, Vincent ^b   Vayssière, Jean Luc ^b   Mignotte, Bernard ^b   Colbère Garapin, Florence ^a   Couderc, Thérèse ^a   Blondel, Bruno ^a  

^a INSTITUT PASTEUR   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; DNA FRAGMENT; MUTANT PROTEIN; PROTEIN CD155; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PERSISTENT INFECTION; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASES; CYTOCHROME C GROUP; ENZYME ACTIVATION; HUMANS; MEMBRANE PROTEINS; MUTATION; NEUROBLASTOMA; POLIOVIRUS; RECEPTORS, VIRUS;

EID: 0037213915     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.1.790-798.2003     Document Type: Article

References (68)

1. Agol, V. I., G. A. Belov, K. Bienz, D. Egger, M. S. Kolesnikova, N. T. Raikhlin, L. I. Romanova, E. A. Smirnova, and E. A. Tolskaya. 1998. Two types of death of poliovirus-infected cells: Caspase involvement in the apoptosis but not cytopathic effect. Virology 252:343-353.
2. Agol, V. I., G. A. Belov, K. Bienz, D. Egger, M. S. Kolesnikova, L. I. Romanova, L. V. Sladkova, and E. A. Tolskaya. 2000. Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle. J. Virol. 74:5534-5541.
3. Agre, J. C., A. A. Rodriguez, and K. B. Sperling. 1989. Symptoms and clinical impressions of patients seen in a post-polio clinic. Arch. Phys. Med. Rehabil. 70:367-370.
4. Ammendolia, M. G., A. Tinari, A. Calcabrini, and F. Superti. 1999. Poliovirus infection induces apoptosis in CaCo-2 cells. J. Med. Virol. 9:122-129.
5. Aoki, J., S. Koike, I. Ise, Y. Satoyoshida, and A. Nomoto. 1994. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269:8431-8438.
6. Aplin, A. E., A. K. Howe, and R. L. Juliano. 1999. Cell adhesion molecules, signal transduction and cell growth. Curr. Opin. Cell Biol. 11:737-744.
7. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099-1106.
8. Barco, A., E. Feduchi, and L. Carrasco. 2000. Poliovirus protease 3C(pro) kills cells by apoptosis. Virology 266:352-360.
9. Bartkowiak, D., S. Hagner, H. Baust, W. Nothdurft, and E. M. Rottinger. 1999. Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-dlacetate. Cytometry 37:191-196.
10. Bellocq, C., K. M. Kean, O. Fichot, M. Girard, and H. Agul. 1987. Multiple mutations involved in the phenotype of a temperature-sensitive small-plaque mutant of poliovirus. Virology 157:75-82.
11. Belnap, D. M., B. M. McDermott, D. J. Filman, N. Q. Cheng, B. L. Trus, H. J. Zuccola, V. R. Racaniello, J. M. Hogle, and A. C. Steven. 2000. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc. Natl. Acad. Sci. USA 97:73-78.
12. Bernhardt, G., J. Harber, A. Zibert, M. de Crombrugghe, and E. Wimmer. 1994. The poliovirus receptor: Identification of domains and amino acid residues critical for virus binding. Virology 203:344-356.
13. Blondel, B., O. Akacem, R. Crainic, P. Couillin, and F. Horodniceanu. 1983. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat inactivated virions. Virology 126:707-710.
14. Blondel, B., G. Duncan, T. Couderc, F. Delpeyroux, N. Pavio, and F. Colbère-Garapin. 1998. Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells. J. Neurovirol. 4:1-26.
15. Bodian, D., and H. A. Howe. 1955. Emerging concept of poliomyelitis infection. Science 122:105-108.
16. Brack, K., W. Frings, A. Dotzauer, and A. Vallbracht. 1998. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J. Virol. 72:3370-3376.
17. Carthy, C. M., D. J. Granville, K. A. Watson, D. R. Anderson, J. E. Wilson, D. Yang, D. W. C. Hunl, and B. M. McManus. 1998. Caspase activation and specific cleavage of substrates after coxsacklevirus B3-induced cytopathic effect in HeLa cells. J. Virol. 72:7669-7675.
18. Colbère-Garapin. F., C. Christodoulou, R. Crainic, and I. Pelletier. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA 86:7590-7594.
19. Colbere-Garapin, F., S. Jacques, A. S. Drillet, N. Pavio, T. Couderc, B. Blondel, and I. Pellelier. 2001. Poliovirus persistence in human cells in vitro. Dev. Biol. 105:99-104.
20. Couderc, T., C. Christodoulou, H. Kopecka, S. Marsden, L. F. Taffs, R. Crainic, and F. Horaud. 1989. Molecular pathogenesis of neural lesions induced by poliovirus type 1. J. Gen. Virol. 70:2907-2918.
21. Couderc, T., J. Delpeyroux, H. Le Blay, and B. Blondel. 1996. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J. Virol. 70:305-312.
22. Dalakas, M. C. 1995. The post-polio syndrome as an evolved clinical entity. Definition and clinical description. Ann. N. Y. Acad. Sci. 753:68-80.
23. Desagher, S., and J. C. Martinou. 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369-377.
24. Destombes, J., T. Couderc, D. Thiesson, S. Girard, S. G. Wilt, and B. Blondel. 1997. Persistent poliovirus infection in mouse motoneurons. J. Virol. 71:1621-1628.
25. Diard, C., J. F. Ravaud, and J. P. Held. 1994. French survey of postpolio sequelae. Risk factors study and medical social outcome. Am. J. Phys. Med. Rehabil. 73:264-267.
26. Earnshaw, W., L. Martins, and S. Kaufmann. 1999. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:383-424.
27. Eberle, F., P. Dubreuil, M. G. Mattei, E. Devilard, and M. Lopez. 1995. The human PRR2 gene related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene 159:267-272.
28. Fagan, E., G. Yausef, J. B. H. Garelick, G. Mann, A. Wolstenholme, B. Portmann, T. Harrison, J. F. Mowbray, A. Mowat, A. Zuckerman, and R. Williams. 1990. Persistence of hepatitis A virus in fulminant hepatitis and after liver transplantation. J. Med. Virol. 30:131-136.
29. Foger, N., R. Marbaba, and M. Zoller. 2000. CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur. J. Immunol. 30:2888-2899.
30. Freistadt, M. S., and K. E. Eberle. 1997. Physical association between CD155 and CD44 in human monocytes. Mol. Immunol. 34:1247-1257.
31. Girard, S., T. Couderc, J. Destombes, D. Thiesson, F. Delpeyroux, and B. Blondel. 1999. Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 73:6066-6072.
32. Goldstaub, D., A. Gradi, Z. Bercovitch, Z. Grosmann, Y. Nophar, S. Luria, N. Sonenherg, and C. Kabana. 2000. Poliovirus 2A protease induces apoptotic cell death. Mol. Cell. Biol. 20:1271-1277.
33. Gromeier, M., S. Lachmann, M. R. Rosenfeld, P. H. Gutin, and E. Wimmer. 2000. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc. Natl. Acad. Sci. USA 97:6803-6808.
34. Gromeier, M., D. Solecki, D. D. Patel, and E. Wimmer. 2000. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: Implications for the pathogenesis of poliomyelitis. Virology 273:248-257.
35. Haller, A. A., and B. L. Semler. 1995. Translation and host cell shutoff, p. 113-133. In H. A. Rothart (ed.). Human Enterovirus Infections. ASM Press. Washington, D.C.
36. He, Y. N., V. D. Bowman, S. Mueller, C. M. Bator, J. Bella, X. H. Peng, T. S. Baker, E. Wimmer, R. J. Kuhn, and M. G. Rossmann. 2000. Interaction of the poliovirus receptor with poliovirus. Proc. Natl. Acad. Sci. USA 97:79-84.
37. Jan, J.-T., and D. E, Griffin. 1999. Induction of apoptosis hy Sindhis virus occurs at cell entry and does not require virus replication. J. Virol. 73:10296-10302.
38. Kaufmann, S. H., and M. O. Hengartner. 2001. Programmed cell death: Alive and well in the new millennium. Trends Cell Biol. 11:526-534.
39. Kischkel, F. C., D. A. Lawrence, A. Tinel, H. LeBlanc, A. Virmani, P. Schow, A. Gazdar, J. Blenis, D. Amott, and A. Ashkenazi. 2001. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276:46639-46646.
40. Koike, S., H. Horie, I. Ise, A. Okitsu, M. Yoshida, N. Iizuka, K. Takeuchi, T. Takegami, and A. Nomoto, 1990. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:3217-3224.
41. Koike, S., I. Ise, and A. Nomoto. 1991. Functional domains of the poliovirus receptor. Proc. Natl. Acad. Sci. USA 88:4104-4108.
42. Koyama, A. H., H. Irie, F. Ueno, M. Ogawa, A. Nomoto, and A. Adachi. 2001. Suppression of apoptotic and necrotic cell death by poliovirus. J. Gen. Virol. 82:2965-2972.
43. Lange, R., X. Peng, E. Wimmer, M. Lipp, and G. Bernhard. 2001. The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 285:218-227.
44. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
45. Lopez, M., F. Eberle, M. G. Mattel, J. Gabert, F. Birg, F. Bardin, C. Maroc, and P. Dubreuil. 1995. Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene 155:261-265.
46. Lopez, M., F. Joedier, F. Bardin, L. Coulombel, C. Chabannon, and P. Dubreuil. 1997. Identification of a new class of Ig superfamily antigens expressed in hemopoiesis, p. 1081. In T. K. Kishimoto, A. E. G. von dem Borne, S. M. Goyert, D. Y. Mason, M. Miyasaka, M. Moretta, K. Okumura, S. Shaw, T. A. Springer, K. Sugamura, and H. Zola (ed.), Leucocyte Typing, Vol. VI. White Cell Differentiation Antigens. Garland Publishing, New York, N.Y.
47. Lopez-Guerero, J. A., M. Alonso, F. Martin-Belmonte, and L. Carrasco. 2000. Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology 272:250-256.
48. Martinez-Moralez, J. R., J. A. Barbas, E. Marti, P. Bovolenta, D. Edgar, and A. Rodriguez-Tébar. 1997. Vitronectin is expressed in the ventral region of the neural tube and promotes the differentiation of motor neurons. Development 124:5139-5147.
49. Masson, D., A. Jarry, B. Baury, P. Blanchardie, C. Laboisse, P. Lustenberger, and M. G. Denis. 2001. Overexpression of the CD155 gene in human colorectal carcinoma. Gut 49:236-240.
50. Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865.
51. Mignotte, B., and J. L. Vayssiere. 1998. Mitochondria and apoptosis. Eur. J. Biochem. 252:1-15.
52. Morrison, M. E., Y. J. He, M. W. Wien, J. M. Hogle, and V. R. Racaniello. 1994. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:2578-2588.
53. Morrison, M. E., and V. R. Racaniello. 1992. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J. Virol. 66:2807-2813.
54. Mueller, S., X. Cae, R. Welker, and E. Wimmer. 2002. Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-I and its implication for poliovirus pathogenesis. J. Biol. Chem. 277;7897-7904.
55. Ohka, S., and A. Nomoto. 2001. Recent insights into poliovirus pathogenesis. Trends Microbiol. 9:501-506.
56. Okamoto, I., Y. Kawano, D. Murakami, T. Sasayama, N. Araki, T. Miki, A. J. Wong, and H. Saya. 2001. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155:755-762.
57. Pavio, N., M.-H. Buc-Caron, and F. Colbère-Garapin. 1996. Persistent poliovirus infection of human fetal brain cells. J. Virol. 70:6395-6401.
58. Pavio, N., T. Couderc, S. Girard, J. Y. Sgro, B. Blondel, and F. Colbère-Garapin. 2000. Expression of mutated receptors in human neuroblastoma cells persistently infected with poliovirus. Virology 274:331-342.
59. Roulston, A., R. Marcellus, and P. E. Branton. 1999. Virus and apoptosis. Annu. Rev. Microbiol. 53:577-628.
60. Shepley, M. P., and V. R. Racaniello. 1994. A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J. Virol. 68:1301-1308.
61. Slee, E. A., H. Zhu, S. C. Chow, M. MacFarlane, D. W. Nicholson, and G. M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21-24.
62. Tafani, M., D. A. Minchenko, A. Serroni, and J. L. Farber. 2001. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res. 61:2459-2466.
63. Takahashi, K., H. Nakanishi, M. Miyabara, K. Mandai, K. Satoh, A. Satoh, H. Nishioka, J. Aoki, A. Nomoto, A. Mizoguchi, and Y. Takai. 1999. Nectin/PRR: An immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with afadin, a PDZ domain-containing protein. J. Cell Biol. 145:539-549.
64. Tolskaya, E. A., L. Romanova, M. S. Kolesnikova, T. A. Ivannikova, E. A. Smimova, N. T. Raikhlin, and V. I. Agol. 1995. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J. Virol. 69:1181-1189.
65. Tsunoda, I., C. I. B. Kurtz, and R. S. Fujinami. 1997. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 228:388-393.
66. Tyler, K. L., P. Clarke, R. L. DeBiasi, D. Kominsky, and G. J. Poggioli. 2001. Reoviruses and the host cell. Trends Microbiol. 9:560-564.
67. Viswanath, V., Y. Wu, R. Boonplueang, S. Chen, F. F. Stevenson, F. Yantiri, L. Yang, M. F. Beal, and J. K. Andersen. 2001. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21:9519-9528.
68. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenke, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331-367.